Log in to search using one of your social media accounts:

 

Birmingham Score Predicts CV Events, Death in ANCA Vasculitis (CME/CE)
(MedPage Today) -- BVAS at presentation served as independent predictor (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 14, 2017 Category: Rheumatology Source Type: news

Pregnant With a Rare Vasculitis: How to Treat Pregnant With a Rare Vasculitis: How to Treat
Dr Stephen Paget reviews the case of a 40-year-old woman with Takayasu arteritis being treated with prednisone.Hospital for Special Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2017 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news

Birmingham Score Predicts CV Events, Death in Vasculitis (CME/CE)
(MedPage Today) -- BVAS at presentation served as independent predictor (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 11, 2017 Category: Cardiology Source Type: news

A Pragmatic Approach to Vasculitis in the GI Tract A Pragmatic Approach to Vasculitis in the GI Tract
What should the pathologist be aware of in terms of the major causes, manifestations, and pathological findings of primary GI vasculitis?Journal of Clinical Pathology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - September 11, 2017 Category: Allergy & Immunology Tags: Pathology & Lab Medicine Journal Article Source Type: news

Shingles: A Link to Vasculitis? (CME/CE)
(MedPage Today) -- History of complicated shingles doubled risk of giant cell arteritis (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - September 3, 2017 Category: Consumer Health News Source Type: news

Joint pain and headache could be warning sign of THIS disease
VASCULITIS is a condition which causes inflammation of the blood vessels - triggered by the immune system. (Source: Daily Express - Health)
Source: Daily Express - Health - August 17, 2017 Category: Consumer Health News Source Type: news

Joint pain and headache could be warning sign of THIS rare disease
VASCULITIS is a condition which causes inflammation of the blood vessels - triggered by the immune system. (Source: Daily Express - Health)
Source: Daily Express - Health - August 17, 2017 Category: Consumer Health News Source Type: news

Vancomycin-Associated HORV:'Devastating Condition'Vancomycin-Associated HORV:'Devastating Condition '
Join in as two ophthalmologists have an in-depth discussion about vancomycin-associated hemorrhagic occlusive retinal vasculitis, including its diagnosis, treatment, and prognosis.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2017 Category: Consumer Health News Tags: Ophthalmology Commentary Source Type: news

IL-6 Blocker Wins in Vasculitis (CME/CE)
(MedPage Today) -- Long-term studies needed to ensure safety (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 27, 2017 Category: Primary Care Source Type: news

Steroids Reasonable in IgA Vasculitis (CME/CE)
(MedPage Today) -- The role of cyclophosphamide remains unclear (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 22, 2017 Category: Primary Care Source Type: news

Cracking the Pathogenesis of Cocaine-Induced Vasculitis Cracking the Pathogenesis of Cocaine-Induced Vasculitis
What have we learned about the mechanisms behind the link between cocaine use and the development of vasculitis?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 5, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Prolonged Therapy Lowers ANCA-Vasculitis Relapse (CME/CE)
(MedPage Today) -- 48 months of azathioprine and steroids showed threefold reduction in relapse risk (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 2, 2017 Category: Primary Care Source Type: news

Monthly News Roundup - May 2017
Actemra: First Drug Approved to Treat Giant Cell Arteritis Actemra (tocilizumab) from Hoffman La Roche has gained a new indication as the first drug approved to treat adults with giant cell arteritis, a specific type of vasculitis. Vasculitis is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 30, 2017 Category: Pharmaceuticals Source Type: news

IL-6 Blocker OK'd for Vasculitis
(MedPage Today) -- FDA approved steroid-sparing tocilizumab for giant cell arteritis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 22, 2017 Category: Primary Care Source Type: news

Actemra Approved for Certain Blood Vessel Inflammation
Drug will treat adults with a condition called vasculitis Source: HealthDay Related MedlinePlus Pages: Giant Cell Arteritis, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 22, 2017 Category: Consumer Health News Source Type: news

FDA approves first drug to specifically treat giant cell arteritis
The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 22, 2017 Category: American Health Source Type: news

Actemra Approved for Certain Blood Vessel Inflammation
MONDAY, May 22, 2017 -- The injected drug Actemra (tocilizumab) has been approved by the U.S. Food and Drug Administration to treat adults with giant cell arteritis, an inflammation of the blood vessels (vasculitis). In a media release Monday, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2017 Category: General Medicine Source Type: news

Diagnosis of cutaneous vasculitis
Classification of cutaneous vasculitis, clinical features, suitable investigations and when to refer to secondary care. (Source: GP Online Education)
Source: GP Online Education - May 17, 2017 Category: Primary Care Tags: 15.10 Skin Problems Source Type: news

Mortality Still High in Vasculitis (CME/CE)
(MedPage Today) -- Risk 2.7-fold higher than in the general population, meta-analysis showed (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 7, 2017 Category: Primary Care Source Type: news

How Common is α -1-Antitrypsin Deficiency?
Discussion α-1-Antitrypsin Deficiency (A1AT) is a common single-gene mutation disease that is homozygous recessive. The normal allele is called M and the most common abnormal allele is Z. There are other alleles though. The gene codes for one of the primary protease inhibitors in the serum, thus those who are homozygous for the Z gene are sometimes referred to as “PIZZ” or “PIZ.” α-1-Antitrypsin is found in all body tissues but is especially important in the serum and lung. As noted it is one of the primary neutrophil protease inhibitors in the serum, and acts to neutralize these enzymes...
Source: PediatricEducation.org - April 24, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Vancomycin-Related Cataract Complications Come Into Focus Vancomycin-Related Cataract Complications Come Into Focus
A review of hemorrhagic occlusive retinal vasculitis clarifies how this rare, but devastating, side effect can occur.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2017 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Damage Starts Early in Kids' Vasculitis (CME/CE)
(MedPage Today) -- Clinical benefits seen year 1 post-diagnosis, but renal damage common (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 6, 2017 Category: Pediatrics Source Type: news

Relapses Common with S. Aureus Nasal Carriage in ANCA-Related Vasculitis (CME/CE)
(MedPage Today) -- Trimethoprim/sulfamethoxazole prophylaxis had no influence on relapse rate (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 6, 2017 Category: Rheumatology Source Type: news

Mixed Results for Biologic in Vasculitis (CME/CE)
(MedPage Today) -- T-cell activation blocking works in giant cell arteritis but not Takayasu's (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 31, 2017 Category: Primary Care Source Type: news

Trials examine immune drug's potential to treat different forms of vasculitis
Two new studies provide valuable insights into the treatment of different types of vasculitis, which are conditions that cause blood vessels to become inflamed. In the studies, investigators examine whether a medication that interferes with the activity of certain immune cells may help treat the most common form of vasculitis, as well as one of the rarest forms, both of which affect the large blood vessels. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 30, 2017 Category: Science Source Type: news

Trials examine immune drug's potential to treat different forms of vasculitis
(Wiley) Two new studies provide valuable insights into the treatment of different types of vasculitis, which are conditions that cause blood vessels to become inflamed. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2017 Category: Global & Universal Source Type: news

FDA Grants Priority Review for Genentech’s Actemra(R) (Tocilizumab) Supplemental Biologics License Application for Giant Cell Arteritis, a Form of Vasculitis
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s Supplemental Biologics Lic... Biopharmaceuticals, FDA Genentech, Roche Group, Actemra, Tocilizumab, Giant Cell Arteritis, Vasculitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 24, 2017 Category: Pharmaceuticals Source Type: news

FDA grants priority review for Roche ’s Actemra/RoActemra (tocilizumab) supplemental biologics license application for giant cell arteritis, a form of vasculitis
Roche announced today that the U.S. Food and Drug Administration (FDA) has accepted the company ’s supplemental biologics license application (sBLA) for Actemra/RoActemra (tocilizumab) for the treatment of GCA, a chronic, potentially life-threatening autoimmune condition. (Source: Roche Investor Update)
Source: Roche Investor Update - January 24, 2017 Category: Pharmaceuticals Source Type: news

ACNA Titers in Vasculitis Decline with B Cell Therapy (CME/CE)
(MedPage Today) -- But drop in immunoglobulin levels less robust (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 10, 2017 Category: Rheumatology Source Type: news

Current and Novel Vasculitis Biomarkers Current and Novel Vasculitis Biomarkers
Dr Desai comments on a study reviewing biomarkers that can diagnose, prognosticate, and monitor disease activity in antineutrophil cytoplasm antibody-associated vasculitis.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 6, 2017 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

Mid-face toddler excoriation syndrome (MiTES): a new paediatric diagnosis - Srinivas SM, Gowda VK, Owen CM, Moss C, Hiremagalore R.
Chronic ulcerating lesions on the face are rarely seen in toddlers. Blistering disease, vasculitis, infections and self-mutilation due to neurometabolic disease can usually be excluded on clinical and histological grounds. In the absence of identifiable di... (Source: SafetyLit)
Source: SafetyLit - January 5, 2017 Category: Global & Universal Tags: Age: Infants and Children Source Type: news

New Risks Posed by Vancomycin Use in Cataract Surgery New Risks Posed by Vancomycin Use in Cataract Surgery
Dr Roger Steinert shares the latest information on hemorrhagic occlusive retinal vasculitis, a new and potentially devastating complication.Medscape Ophthalmology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 12, 2016 Category: Allergy & Immunology Tags: Ophthalmology Commentary Source Type: news

FDA grants breakthrough therapy designation for Roche ’s Actemra/RoActemra in giant cell arteritis, a form of vasculitis
Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation status to Actemra/RoActemra ® (tocilizumab) for giant cell arteritis (GCA), a chronic, potentially life-threatening autoimmune condition. (Source: Roche Media News)
Source: Roche Media News - October 5, 2016 Category: Pharmaceuticals Source Type: news

FDA grants breakthrough therapy designation for Roche ’s Actemra/RoActemra in giant cell arteritis, a form of vasculitis
Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation status to Actemra/RoActemra ® (tocilizumab) for giant cell arteritis (GCA), a chronic, potentially life-threatening autoimmune condition. (Source: Roche Investor Update)
Source: Roche Investor Update - October 5, 2016 Category: Pharmaceuticals Source Type: news

Recommendations for Managing ANCA-Associated Vasculitis Recommendations for Managing ANCA-Associated Vasculitis
What are the best strategies for managing antineutrophil cytoplasmic antibody-associated vasculitis? Find out what the experts recommend.Annals of the Rheumatic Diseases (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 3, 2016 Category: Allergy & Immunology Tags: Rheumatology Journal Article Source Type: news

Vancomycin in Cataract Procedures May Cause Blindness Vancomycin in Cataract Procedures May Cause Blindness
Researchers have documented 35 eyes with severe hemorrhagic occlusive retinal vasculitis after treatment with vancomycin during cataract procedures.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 15, 2016 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Vasculitis
Title: VasculitisCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/11/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 11, 2016 Category: Rheumatology Source Type: news

Temporal (Giant Cell) Arteritis: 3 Questions You were Afraid to Ask
The large vessel vasculitis is more common among older adults and extremely dangerous if missed. Get answers to 3 questions you should ask. (Source: ConsultantLive)
Source: ConsultantLive - July 20, 2016 Category: Internal Medicine Authors: Gregory W. Rutecki, MD Source Type: news

EULAR: New Recommendations for Treating Vasculitis (CME/CE)
(MedPage Today) -- "This clearly reflects the standard of care," says U.S. expert (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - June 29, 2016 Category: Consumer Health News Source Type: news

Report: ChemoCentryx’s CCX168 can meet major unmet needs in vasculitis patients
CCX 168, a small molecule being developed by US-based, clinical-stage biopharmaceutical company ChemoCentryx, is a potential treatment for a number of major unmet needs in vasculitis patients and has significant advantages over its competitors, accor… (Source: Drug Development Technology)
Source: Drug Development Technology - May 26, 2016 Category: Pharmaceuticals Source Type: news

Rare Vasculitis Less So in Minorities (CME/CE)
(MedPage Today) -- Takayasu arteritis more common in immigrants to Norway (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 19, 2016 Category: Primary Care Source Type: news

Arzerra: An Alternate Tx in Vasculitis (CME/CE)
(MedPage Today) -- B-cell depletion successful in patients who didn't respond to Rituxan (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 3, 2016 Category: Primary Care Source Type: news

No Vasculitis Risk for TNF Treatment (CME/CE)
(MedPage Today) -- Paradoxical adverse event no higher than with conventional therapies (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - April 27, 2016 Category: Journals (General) Source Type: news

Vasculitis after snorting cocaine contaminated with levamisole
Lawrence et al. Allergy Rhinol (Providence) 2014Copyright policy — open-access 3.5 out of 5 stars Cocaine-induced ecchymotic rash. Voore NK. Cleve Clin J Med 2016 Apr;3:252-253. Full Text Since at least 2010, a large percentage of cocaine samples seized in the United States has contained levamisole, a veterinary anti-worm medication. Levamisole had previously used in humans as an anti-helminthic and also in some chemotherapy regimens. It was withdrawn from the U.S. market in 1999 because of its association with agranulocytosis and vasculitis. It is apparently added to cocaine because it increases catecholamine r...
Source: The Poison Review - April 7, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical cocaine levamisole vasculitis Source Type: news

Actemra Found Steroid-Sparing in Vasculitis (CME/CE)
(MedPage Today) -- Tocilizumab induced remission, prevented relapse in giant cell arteritis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 11, 2016 Category: Primary Care Source Type: news

B-Cell-Targeted Therapy in Systemic VasculitisB-Cell-Targeted Therapy in Systemic Vasculitis
How effective is B-cell-targeted therapy in the treatment of various forms of systemic vasculitis? Current Opinion in Rheumatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 4, 2016 Category: Pathology Tags: Rheumatology Journal Article Source Type: news

Henoch-Schönlein purpura following high-voltage electric burn injury: A case report and review of the literature - Duan X, Yu D, Yu C, Wang B, Guo Y.
Henoch-Schönlein Purpura (HSP) is a systemic vasculitis of unknown cause, with immune-mediated inflammation of the small vessels, which is characterized by a series of clinical symptoms, such as purpuric rash, colicky abdominal pain, arthritis and acute g... (Source: SafetyLit)
Source: SafetyLit - February 26, 2016 Category: Global & Universal Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Relapse Common in ANCA-Associated Vasculitis (CME/CE)
(MedPage Today) -- But survival and ESRD-free survival have improved since the 1980s (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 8, 2016 Category: Rheumatology Source Type: news

ANCA Vasculitis: Early Hypoxemia Is Bad Omen (CME/CE)
(MedPage Today) -- Remission more likely with rituximab than with cyclophosphamide (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 11, 2016 Category: Rheumatology Source Type: news

Chemotherapy Isn't Only for Cancer Patients
When you hear the word chemotherapy what immediately comes to mind? Cancer. Bald. Nausea. Vomiting. Infusions. Sterility. Bone Pain? Upon hearing that word, most people jump to the same conclusions, with the same general consensus on how chemo works, who receives it, and what side effects it has on the body. The truth is chemotherapy isn't only for cancer patients, and affects each patient differently depending on how it is used. Chemotherapy is a widely used class of drugs to treat many different disorders including, but not limited to: cancers, blood disorders, and a plethora of autoimmune diseases. Similarly it can be ...
Source: Healthy Living - The Huffington Post - December 8, 2015 Category: Consumer Health News Source Type: news